ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 133 filers reported holding ARRAY BIOPHARMA INC in Q3 2013. The put-call ratio across all filers is 16.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $460,000 | -4.4% | 9,924 | -49.8% | 0.05% | -57.5% |
Q1 2019 | $481,000 | +80.1% | 19,762 | +5.4% | 0.11% | +73.8% |
Q4 2018 | $267,000 | -36.1% | 18,752 | -31.7% | 0.06% | -20.7% |
Q3 2018 | $418,000 | -6.7% | 27,475 | +2.9% | 0.08% | -7.9% |
Q2 2018 | $448,000 | +41.8% | 26,700 | +37.9% | 0.09% | +34.8% |
Q1 2018 | $316,000 | +73.6% | 19,368 | +36.2% | 0.07% | +83.3% |
Q4 2017 | $182,000 | +127.5% | 14,222 | +59.3% | 0.04% | +200.0% |
Q1 2017 | $80,000 | -5.9% | 8,930 | -8.2% | 0.01% | -7.7% |
Q4 2016 | $85,000 | -11.5% | 9,725 | -31.5% | 0.01% | 0.0% |
Q3 2016 | $96,000 | +242.9% | 14,200 | +151.5% | 0.01% | +550.0% |
Q4 2013 | $28,000 | -40.4% | 5,647 | -25.8% | 0.00% | -50.0% |
Q3 2013 | $47,000 | +11.9% | 7,612 | -16.8% | 0.00% | 0.0% |
Q2 2013 | $42,000 | – | 9,152 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 9,169,276 | $66,110,000 | 11.67% |
Redmile Group, LLC | 13,623,620 | $98,226,000 | 8.05% |
First Light Asset Management, LLC | 849,374 | $6,124,000 | 2.88% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 9,529,361 | $68,707,000 | 2.29% |
Opus Point Partners Management, LLC | 320,000 | $2,307,000 | 1.83% |
KOPP INVESTMENT ADVISORS LLC | 383,022 | $2,762,000 | 1.23% |
Artal Group S.A. | 3,710,000 | $26,749,000 | 1.15% |
EcoR1 Capital, LLC | 400,000 | $2,884,000 | 0.96% |
Cormorant Asset Management, LP | 850,000 | $6,129,000 | 0.82% |
SPHERA FUNDS MANAGEMENT LTD. | 800,000 | $5,768,000 | 0.56% |